Cargando…
Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis
Metabolic acidosis is a common complication of chronic kidney disease (CKD). Veverimer is an orally administrated, free amine polymer with high capacity and binding selectivity to hydrochloric acid from the gastrointestinal tract. This study pooled the current evidence of the efficacy and safety of...
Autores principales: | Liu, Wenlin, Li, Lili, Zhang, Xuemei, Dong, Haonan, Lu, Miaomiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117340/ https://www.ncbi.nlm.nih.gov/pubmed/33995050 http://dx.doi.org/10.3389/fphar.2021.643128 |
Ejemplares similares
-
Veverimer for treatment of chronic metabolic acidosis in patients with chronic kidney disease
por: Gone, Anirudh R., et al.
Publicado: (2020) -
Veverimer: an advance in base therapy for metabolic acidosis
por: Brady, Clayton, et al.
Publicado: (2020) -
Effects of Veverimer in Older Adults With CKD and Metabolic Acidosis
por: Tangri, Navdeep, et al.
Publicado: (2021) -
Safety and Efficacy of Veverimer in Acidotic Patients With CKD and Heart Failure
por: Mathur, Vandana, et al.
Publicado: (2021) -
Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial
por: Mathur, Vandana S., et al.
Publicado: (2022)